Search bioRxiv⌕ Search

Biology subjects

Deegan, D. F.

Publications and source records attributed to Deegan, D. F..

2 recordsLinked to original sources

Four Core Genotypes Mice Exhibit Quantitative Differences in T and B Cell Subpopulations compared to Wild-type Mice.

It has been well established that females have a more active immune system. Females respond better to vaccines, are more resistant to somatic cell cancers, display better pathogen responses, present antigens better, and, conversely, are more prone to autoimmune diseases compared to male counterparts. Though these trends have been observed across normal and pathogenic states, the mechanisms underlying these sex differences have not been fully explained. Some hormonal effects on immune cell populations have been reported, but much less is known about effects contributed by genes on the sex chromosomes, for example those that are more highly expressed in females due to X inactivation escape, or Y-linked genes those unique to males. Here we use the Four Core Genotypes (FCG) mouse model and wildtype XY male mice to disentangle the effects of sex hormones, sex chromosome complement, and their interactions on baseline B and T cell populations in the periphery and T cells in the thymus. We test the effects of a previously described X-Y chromosomal translocation and those of the Sry transgene insertion on chromosome 3. We observe that mice harboring the Sry transgene show significant depletion of peripheral CD8+ T cell subpopulations. In the thymus, the XY XY,but not the XX males, show significant decrease to both CD8+ and CD4+ single positive T cells and an increase to CD4/CD8 double positive T cells. We also show that Y chromosome-bearing mice exhibit depletion in splenic marginal zone B cells. Our data suggests that the gonadal sex is the strongest contributor to this phenotype. Our studies define a critical framework for the use of this model and provide valuable data to assess the use of the FCGs model, especially for diseases involving the immune response.

immunology↗

Sex chromosomes and sex hormones contribute jointly and independently to sex biases in cardiac development.

Congenital heart defects are highly sex-biased, and although the regulatory networks underlying the differentiation of cardiac progenitors are well established, the sex differences during early stages of cardiogenesis have been largely understudied. Traditionally, sex differences are attributed to the gonadal sex hormones, but the unequal sex chromosome complement (i.e., XX versus XY) contributes to sex-biased gene expression from soon after fertilization and across the lifespan. We leveraged the Four Core Genotypes (FCG) mouse model to investigate gonadal and sex chromosome effects on the transcriptome during cardiac development. We found significant sex-biased gene expression at all developmental stages, including in 10.5 dpc (days post-coitum) embryos, before the gonads have formed. Our studies reveal that sex differences in the transcriptome are governed by both sex chromosome and gonadal sex hormone effects and their interactions in 16.5 dpc, neonates, and adults, to differing degrees depending on the stage. Transcriptional and epigenetic factors were among the differentially expressed genes, suggesting the existence of sex-specific subnetworks. The adult cardiac epigenome was also investigated for differential H3K27Ac enrichment, revealing sex-biased chromatin states containing transcription factor binding sites regulated by sex chromosomes, gonadal hormones, and their combined effects. Several of these differentially enriched regions were found to overlap with known cardiac enhancers and correlated with differential expression of typical cardiac-specific genes.

developmental biology↗